Novo Nordisk A/S (BSP:N1VO34)
R$ 93.5 -1.7 (-1.79%) Market Cap: 416.29 Bil Enterprise Value: 411.68 Bil PE Ratio: 45.42 PB Ratio: 36.10 GF Score: 94/100

Q1 2019 Novo Nordisk A/S Earnings Call Transcript

May 03, 2019 / 11:00AM GMT
Operator

Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's Q1 2019 Novo Nordisk A/S Earnings Conference Call. (Operator Instructions) I must advise you, the conference today has been recorded on Friday, the 3rd of May 2019.

Without any further delay, I would like to hand the conference over to your first speaker today, Lars Fruergaard Jørgensen. Please go ahead, sir.

Lars Fruergaard JÃ;rgensen;S;President;CEO
Novo Nordisk A

¸ - /-&

Thank you very much. Welcome to this Novo Nordisk conference call regarding our performance in the first 3 Months of 2019 and our outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. With me, I have our Chief Financial Officer, Karsten Munk Knudsen; and our Chief Science Officer, Mads Krogsgaard Thomsen. Also present and available for the Q&A session are Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest; and Executive Vice President and Head of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot